PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-02-16

Date Title Company
16-Feb-2022 K3-Innovations Has Retained Biopharmaceutical Development Veteran Jim Baker to Drive Expansion of Its Clinical Research Offerings Newswire
16-Feb-2022 PerkinElmer’s SIRION Biotech Teams with Centre for Genomic Regulation to Develop New Generation AAV Vectors for Type 1 and Type 2 Diabetes Gene Therapy PerkinElmer
16-Feb-2022 Top 5 Pharma Looks to LifeSphere IDMP for Regulatory Readiness ArisGlobal
16-Feb-2022 Biotest AG: Biotest exceeds Revenue guidance 2021 Biotest AG
16-Feb-2022 Pain Therapeutics - Keynote Opening Addresses From The Pain Society And Eptiva Therapeutics SMi Group
16-Feb-2022 Two Million Euros for XO Life GmbH's Patient Insights Platform B3C newswire
16-Feb-2022 European Commission Approves Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older Global Blood Therapeutics, Inc.
16-Feb-2022 atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS) to Support Pioneering Work in Psychedelic Medicine atai Life Sciences
16-Feb-2022 Mechanical Properties of Biological Tissues Described the Easy Way Karl Landsteiner University of Health Sciences
16-Feb-2022 New PROFINET-enabled pumps from Watson-Marlow enable seamless integration of fluid delivery up to enterprise-level Sciad Newswire
16-Feb-2022 Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus AstraZeneca
16-Feb-2022 Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus AstraZeneca
16-Feb-2022 European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults Pfizer
16-Feb-2022 Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency Pfizer
16-Feb-2022 Boyds boosts specialist clinical expertise with new hire Boyds
16-Feb-2022 MODERNA ANNOUNCES PLAN TO EXPAND FOOTPRINT IN ASIA WITH FOUR ADDITIONAL SUBSIDIARIES MODERNA
16-Feb-2022 Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform Curve Therapeutics
16-Feb-2022 SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline SpliceBio
16-Feb-2022 Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicines Over the Next Ten Years Moderna, Inc.
16-Feb-2022 Defence Therapeutics Inc.: DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER Defence Therapeutics Inc.